Stay updated with breaking news from Ablation System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
12-month results reinforce versatility and durability for the treatment of paroxysmal and persistent AFib with the first-of-its-kind pulsed field ablation, radiofrequency, and high density mapping Sphere-9 CatheterÂ
AtriCure, Inc. , a leading innovator in surgical treatments and therapies for atrial fibrillation , left atrial appendage management and post-operative pain management, today announced that the... | April 19, 2023
Medtronic announced today that it received CE mark approval for its Affera mapping and ablation system.
Trial will evaluate the safety and effectiveness of the AtriCure AtriClip Left Atrial Appendage Exclusion System for stroke prevention in cardiac surgery patients AtriCure, Inc. (Nasdaq: ATRC),
Minerva Surgical (NASDAQ:UTRS – Get Rating) and QHSLab (OTCMKTS:USAQ – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability and analyst recommendations. Earnings and Valuation This table compares Minerva Surgical and QHSLab’s […]